ResearcherScripps Research InstituteActive in the last 2 years

Po‐Kai Chuang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2585-3299; OpenAlex author ID A5043886447, A5049716230. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 2 papers

Papers 2

Drug repurposing of 6-AZA-UTP and itraconazole reveals novel B3GALT5 inhibitors for pancreatic cancer. Last author DOI 10.1016/j.bioorg.2025.108464 ↗
Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade. Co-author DOI 10.1073/pnas.2517415122 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chi‐Huey Wong · 1 shared paper, 2025 · strength 0.37
- Paper Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune che… DOI 10.1073/pnas.2517415122 ↗
Lavanya Botcha · 1 shared paper, 2025 · strength 0.30
- Paper Drug repurposing of 6-AZA-UTP and itraconazole reveals novel B3GALT5 inhibitors for pancreatic cancer. DOI 10.1016/j.bioorg.2025.108464 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.